Anti-TNF agents and new biological agents (Vedolizumab and Ustekinumab) in the prevention and treatment of postoperative recurrence after surgery in Crohn's …

JP Gisbert, M Chaparro - Drugs, 2023 - Springer
Surgery for Crohn's disease (CD) is not curative, as postoperative recurrence (POR) after
ileocolonic resection is the rule in the absence of prophylactic treatment. In the present …

The Management of Postoperative Recurrence in Crohn's Disease

E Fasulo, F D'Amico, L Osorio, M Allocca… - Journal of Clinical …, 2023 - mdpi.com
Crohn's disease (CD) is a chronic inflammatory bowel disease with different phenotypes of
presentation, inflammatory, penetrating, or stricturing disease, that significantly impacts …

Prophylactic Versus Endoscopy-driven Treatment of Crohn's Postoperative Recurrence: A Retrospective, Multicentric, European Study [PORCSE Study]

J Geldof, M Truyens, M Hanssens… - Journal of Crohn's …, 2024 - academic.oup.com
Abstract Background and Aims No consensus exists on optimal strategy to prevent
postoperative recurrence [POR] after ileocaecal resection [ICR] for Crohn's disease [CD]. We …

Management of Post-Operative Crohn's Disease: Knowns and Unknowns

M Spertino, R Gabbiadini, A Dal Buono… - Journal of Clinical …, 2024 - mdpi.com
Crohn's disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract
characterized by relapsing–remission phases. CD often requires surgical intervention during …

Systematic review: Patient‐related, microbial, surgical, and histopathological risk factors for endoscopic post‐operative recurrence in patients with Crohn's disease

MTJ Bak, K Demers, N Hammoudi… - Alimentary …, 2024 - Wiley Online Library
Background Risk stratification for endoscopic post‐operative recurrence (ePOR) in Crohn's
disease (CD) is required to identify patients who would benefit most from initiation of …

Postoperative management of Crohn's disease: One size does not fit all

E Domènech, M Mañosa… - United European …, 2023 - Wiley Online Library
It was in the late eighties and early nineties that the Leuven's group led by Paul Rutgeerts
published a series of landmark studies describing the natural history of postoperative …

Efficacia e sicurezza di Vedolizumab versus Ustekinumab nel prevenire la recidiva post-operatoria nella malattia di Crohn

L FERRARO - thesis.unipd.it
Background: Crohn's Disease (CD) is a chronic inflammatory disease characterized by a
relapsing and remitting transmural inflammation of the gastrointestinal tract. Surgical …

[PDF][PDF] Caroline Soares1; Sofia Ventura1; Cláudio Rodrigues1; Ângela Domingues1

R Gomes, P Ministro - xxxiicongresso.spcoloprocto.org
Several risk factors for recurrence after resection surgery in Crohn's disease (CD) have been
identified. In clinical practice, patients are divided in high or low risk groups and the …